MCQOPTIONS
Saved Bookmarks
| 1. |
Indigenous Covid-19 vaccine Covaxin has demonstrated interim clinical efficacy of how much per cent in its phase three trial? |
| A. | 61 |
| B. | 71 |
| C. | 81 |
| D. | 91 |
| E. | 99 |
| Answer» D. 91 | |